María del Carmen Martínez-Cuesta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
María del Carmen Martínez-Cuesta has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
- Teresa Requena
Laboratory of Functional Biology of Lactic Acid Bacteria, Department of Biotechnology and Food Microbiology, Institute of Food Science Research (CIAL), CSIC-UAM, 28049, Madrid, Spain
43 shared publications Carmen Peláez
Department of Food Biotechnology and Microbiology, Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC-UAM), Madrid, Spain
30 shared publicationsTeresa Requena
Department of Food Biotechnology and Microbiology, Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC-UAM), Nicolás Cabrera 9, 28049 Madrid, Spain
7 shared publications- Tomás García-Cayuela
Tecnológico de Monterrey, Escuela de Ingeniería y Ciencias
7 shared publications - Begoña Bartolomé
Institute of Food Science Research (CIAL), CSIC-UAM, 28049 Madrid, Spain
6 shared publications Elvira Barroso
Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC-UAM), CEI (UAM+CSIC), Nicolás Cabrera 9, 28049 Madrid, Spain
6 shared publications
Latest Publications
- Open Access
- 21 April 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (17) , 13990-13997
Human Gut Microbiome Can Degrade the Sweetener Acesulfame K with Potential Damaging Effects in the Intestinal Barrier Function
Acesulfame K (Ace-K) is a commonly consumed sweetener, although knowledge about the Ace-K-gut microbiota interaction remains limited. This study evaluates dose-dependent effects of Ace-K on metataxonomics, metagenomics, and metabolic activity of children gut microbiota developed in a dynamic gut simulator. An Ace-K-dose dependent increase in Anaerostipes, Coprococcus, Subdoligranulum, Blautia, Sutterella wadsworthensis, Alistipes, and Bacteroides thetaiotaomicron was observed. Butyrate showed a dose–response increase that correlated with Ace-K consumption, suggesting its microbial metabolism. Increasing bacterial taxa showed sulfatase and amidase activities potentially capable of degrading Ace-K, releasing sulfamate and acetoacetate, which species such as Anaerostipes hadrus and Intestinimonas can metabolize to produce butyrate via the butanoyl-CoA pathway. Furthermore, the Ace-K-microbiome interaction led to a dose-dependent decrease in Caco-2 epithelial integrity, possibly due to the release of sulfated metabolites. This study provides evidence of the potential risk of Ace-K consumption based on its metabolism by the human gut microbiome.
- 21 April 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (17) , 13990-13997
Open AccessHuman Gut Microbiome Can Degrade the Sweetener Acesulfame K with Potential Damaging Effects in the Intestinal Barrier Function
Acesulfame K (Ace-K) is a commonly consumed sweetener, although knowledge about the Ace-K-gut microbiota interaction remains limited. This study evaluates dose-dependent effects of Ace-K on metataxonomics, metagenomics, and metabolic activity of children gut microbiota developed in a dynamic gut simulator. An Ace-K-dose dependent increase in Anaerostipes, Coprococcus, Subdoligranulum, Blautia, Sutterella wadsworthensis, Alistipes, and Bacteroides thetaiotaomicron was observed. Butyrate showed a dose–response increase that correlated with Ace-K consumption, suggesting its microbial metabolism. Increasing bacterial taxa showed sulfatase and amidase activities potentially capable of degrading Ace-K, releasing sulfamate and acetoacetate, which species such as Anaerostipes hadrus and Intestinimonas can metabolize to produce butyrate via the butanoyl-CoA pathway. Furthermore, the Ace-K-microbiome interaction led to a dose-dependent decrease in Caco-2 epithelial integrity, possibly due to the release of sulfated metabolites. This study provides evidence of the potential risk of Ace-K consumption based on its metabolism by the human gut microbiome.
- Open Access
Prebiotic Effect of Polysaccharides and Flavonoids from Passiflora foetida Fruits on the Human Intestinal Microbiota Associated with Obesity
Passiflora foetida fruit is rich in beneficial polysaccharides and flavonoids. Recent studies have found that these polysaccharides and flavonoids may influence health through interaction with the gut microbiota, for example by modification of the microbial composition or by conversion of the polysaccharides and flavonoids to further bioactive compounds. In the current study, a three-stage dynamic simulator of the human gut microbiota, namely BFBL gut model, inoculated with either normal-weight or obese fecal bacteria, was tested with two aqueous-extracted fractions from P. foetida fruit, containing complex dietary P. foetida polysaccharides (PFP) and P. foetida flavonoids (PFF) mixtures, respectively. Within the context of the gut model, the effects of these interventions on targeted microbial composition as well as metabolite levels were assessed. The results showed that the consumption of PFP and PFF could modulate the microbiota associated to obesity, through regulating the abundance of several microbial groups (Alistipes, Bacteroides, Faecalibacterium and sulphate-reducing bacteria) and enriching the short-chain fatty acids (SCFAs) production, to the levels closer to those in the normal-weight microbiota. Furthermore, this study demonstrated that these complex polysaccharides and flavonoids in the context of an in vitro dynamic gut model showed prebiotic effects on the human intestinal microbiota by modulating some anti-obesity-related bacteria such as Akkermansia and Faecalibacterium as well as an increase of propionic acid production by the obese microbiota. These microbiota members represent novel targets of P. foetida fruit polysaccharides and flavonoids degrading or resistant microbes to be validated under physiological conditions in vivo and further investigated for P. foetida fruit beneficial effects.
Open AccessPrebiotic Effect of Polysaccharides and Flavonoids from Passiflora foetida Fruits on the Human Intestinal Microbiota Associated with Obesity
Passiflora foetida fruit is rich in beneficial polysaccharides and flavonoids. Recent studies have found that these polysaccharides and flavonoids may influence health through interaction with the gut microbiota, for example by modification of the microbial composition or by conversion of the polysaccharides and flavonoids to further bioactive compounds. In the current study, a three-stage dynamic simulator of the human gut microbiota, namely BFBL gut model, inoculated with either normal-weight or obese fecal bacteria, was tested with two aqueous-extracted fractions from P. foetida fruit, containing complex dietary P. foetida polysaccharides (PFP) and P. foetida flavonoids (PFF) mixtures, respectively. Within the context of the gut model, the effects of these interventions on targeted microbial composition as well as metabolite levels were assessed. The results showed that the consumption of PFP and PFF could modulate the microbiota associated to obesity, through regulating the abundance of several microbial groups (Alistipes, Bacteroides, Faecalibacterium and sulphate-reducing bacteria) and enriching the short-chain fatty acids (SCFAs) production, to the levels closer to those in the normal-weight microbiota. Furthermore, this study demonstrated that these complex polysaccharides and flavonoids in the context of an in vitro dynamic gut model showed prebiotic effects on the human intestinal microbiota by modulating some anti-obesity-related bacteria such as Akkermansia and Faecalibacterium as well as an increase of propionic acid production by the obese microbiota. These microbiota members represent novel targets of P. foetida fruit polysaccharides and flavonoids degrading or resistant microbes to be validated under physiological conditions in vivo and further investigated for P. foetida fruit beneficial effects.
- 11 March 2025
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 105 (9) , 4854-4862
Lacticaseibacillus rhamnosusGG improves behavior, immune functions, and biological age markers in female mice with premature aging
Background: Prematurely aged mice (PAM), characterized by an inadequate stress response, exhibit early immunosenescence and reduced lifespan compared with exceptional non‐PAM (E‐NPAM) of the same age. Lacticaseibacillus rhamnosus GG (LGG) has been proposed as a beneficial probiotic in healthy aging. This study aimed to evaluate the effects of LGG consumption over 2 and 4 weeks on behavioral parameters, peritoneal leukocyte function, and lifespan in adult female PAM.Results: Female ICR‐CD1 mice were classified as either PAM or E‐NPAM and divided into three groups: (1) PAM control (PAMC), (2) PAM receiving LGG (PAMLGG), and (3) E‐NPAM control (E‐NPAMC). The PAMLGG group consumed a lyophilized LGG suspension in skim milk for 4 weeks, while the PAMC and E‐NPAMC groups received a skim milk solution. Behavioral tests were conducted after 2 weeks, and leukocyte function was analyzed after 2 and 4 weeks. The results showed that the PAMLGG group exhibited improved behavioral responses and enhanced immune functions, which was reflected in a lower biological age and in a longer longevity compared with the PAMC.Conclusion: LGG supplementation positively influenced behavior, immune function, and biological age markers in female PAM, leading to increased longevity. These findings indicate that LGG administration could be a good nutritional strategy for slowing down the aging process, allowing a healthy longevity to be achieved. © 2025 Society of Chemical Industry.
- 11 March 2025
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 105 (9) , 4854-4862
Lacticaseibacillus rhamnosusGG improves behavior, immune functions, and biological age markers in female mice with premature aging
Background: Prematurely aged mice (PAM), characterized by an inadequate stress response, exhibit early immunosenescence and reduced lifespan compared with exceptional non‐PAM (E‐NPAM) of the same age. Lacticaseibacillus rhamnosus GG (LGG) has been proposed as a beneficial probiotic in healthy aging. This study aimed to evaluate the effects of LGG consumption over 2 and 4 weeks on behavioral parameters, peritoneal leukocyte function, and lifespan in adult female PAM.Results: Female ICR‐CD1 mice were classified as either PAM or E‐NPAM and divided into three groups: (1) PAM control (PAMC), (2) PAM receiving LGG (PAMLGG), and (3) E‐NPAM control (E‐NPAMC). The PAMLGG group consumed a lyophilized LGG suspension in skim milk for 4 weeks, while the PAMC and E‐NPAMC groups received a skim milk solution. Behavioral tests were conducted after 2 weeks, and leukocyte function was analyzed after 2 and 4 weeks. The results showed that the PAMLGG group exhibited improved behavioral responses and enhanced immune functions, which was reflected in a lower biological age and in a longer longevity compared with the PAMC.Conclusion: LGG supplementation positively influenced behavior, immune function, and biological age markers in female PAM, leading to increased longevity. These findings indicate that LGG administration could be a good nutritional strategy for slowing down the aging process, allowing a healthy longevity to be achieved. © 2025 Society of Chemical Industry.
- Open Access
- 6 January 2025
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 196, 115236
Polysorbate 80 and carboxymethylcellulose: A different impact on epithelial integrity when interacting with the microbiome
- 6 January 2025
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 196, 115236
Open AccessPolysorbate 80 and carboxymethylcellulose: A different impact on epithelial integrity when interacting with the microbiome
- Open Access
- 5 January 2025
- Published by Elsevier in Food Bioscience
- Vol. 64
Microbiome mediated impact of food grade carrageenan on the intestinal barrier function
- 5 January 2025
- Published by Elsevier in Food Bioscience
- Vol. 64
Open AccessMicrobiome mediated impact of food grade carrageenan on the intestinal barrier function
- Open Access
- 23 May 2024
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 15 (12) , 6759-6767
Influence of consumption of the food additive carrageenan on the gut microbiota and the intestinal homeostasis of mice
The risks associated with carrageenan intake through its hydrolysis by the gut microbiome is studied.
- 23 May 2024
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 15 (12) , 6759-6767
Open AccessInfluence of consumption of the food additive carrageenan on the gut microbiota and the intestinal homeostasis of mice
The risks associated with carrageenan intake through its hydrolysis by the gut microbiome is studied.
- Open Access
Immunological Activity and Gut Microbiota Modulation of Pectin from Kiwano (Cucumis metuliferus) Peels
For developing the recycling of fruit by-products from kiwano, a polysaccharide was extracted from kiwano (Cucumis metuliferus) peels, namely Cucumis metuliferus peels polysaccharide (CMPP), with the aim of investigating the potential beneficial effects. The composition of polysaccharides was analyzed by chemical methods. RAW264.7 macrophages cells and the microbiota dynamics simulator (BFBL gut model) were used for in vitro study. The result showed that CMPP mainly consists of glucuronic acid, arabinose, galactose and rhamnose. By intervening with RAW264.7 cells, CMPP promoted cell proliferation and showed immune-enhancing activity, which significantly (p < 0.05) induced the release of nitric oxide (NO), tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) at a concentration of 50 μg/mL. In addition, CMPP had an impact on the composition of the gut bacteria, increasing the growth of Akkermansia, Bacteroides, Bifidobacterium, Feacalibacterium, and Roseburia. During the intake period, acetic, butyric and propionic acids were all increased, especially (p < 0.05) in the descending colon. Moreover, a decrease in ammonia concentration (10.17 ± 0.50 mM in the ascending colon, 13.21 ± 1.54 mM in the transverse colon and 13.62 ± 0.45 mM in the descending colon, respectively) was observed. In summary, CMPP can be considered as a pectin, showed immunological activity and function of gut microbiota modulation. This study could be the scientific basis of developing kiwano peels as beneficial to human health.
Open AccessImmunological Activity and Gut Microbiota Modulation of Pectin from Kiwano (Cucumis metuliferus) Peels
For developing the recycling of fruit by-products from kiwano, a polysaccharide was extracted from kiwano (Cucumis metuliferus) peels, namely Cucumis metuliferus peels polysaccharide (CMPP), with the aim of investigating the potential beneficial effects. The composition of polysaccharides was analyzed by chemical methods. RAW264.7 macrophages cells and the microbiota dynamics simulator (BFBL gut model) were used for in vitro study. The result showed that CMPP mainly consists of glucuronic acid, arabinose, galactose and rhamnose. By intervening with RAW264.7 cells, CMPP promoted cell proliferation and showed immune-enhancing activity, which significantly (p < 0.05) induced the release of nitric oxide (NO), tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) at a concentration of 50 μg/mL. In addition, CMPP had an impact on the composition of the gut bacteria, increasing the growth of Akkermansia, Bacteroides, Bifidobacterium, Feacalibacterium, and Roseburia. During the intake period, acetic, butyric and propionic acids were all increased, especially (p < 0.05) in the descending colon. Moreover, a decrease in ammonia concentration (10.17 ± 0.50 mM in the ascending colon, 13.21 ± 1.54 mM in the transverse colon and 13.62 ± 0.45 mM in the descending colon, respectively) was observed. In summary, CMPP can be considered as a pectin, showed immunological activity and function of gut microbiota modulation. This study could be the scientific basis of developing kiwano peels as beneficial to human health.
- Open Access
- 16 June 2021
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 11
Taxonomic Characterization and Short-Chain Fatty Acids Production of the Obese Microbiota
Intestinal microbiota seems to play a key role in obesity. The impact of the composition and/or functionality of the obesity-associated microbiota have yet to be fully characterized. This work assessed the significance of the taxonomic composition and/or metabolic activity of obese- microbiota by massive 16S rRNA gene sequencing of the fecal microbiome of obese and normoweight individuals. The obese metabolic activity was also assessed by in vitro incubation of obese and normoweight microbiotas in nutritive mediums with different energy content. We found that the microbiome richness and diversity of the two groups did not differ significantly, except for Chao1 index, significantly higher in normoweight individuals. At phylum level, neither the abundance of Firmicutes or Bacteroidetes nor their ratio was associated with the body mass index. Besides, the relative proportions in Collinsella, Clostridium XIVa, and Catenibacterium were significantly enriched in obese participants, while Alistipes, Clostridium sensu stricto, Romboutsia, and Oscillibacter were significantly diminished. In regard to metabolic activity, short-chain fatty acids content was significant higher in obese individuals, with acetate being the most abundant followed by propionate and butyrate. Acetate and butyrate production was also higher when incubating obese microbiota in mediums mimicking diets with different energy content; interestingly, a reduced capability of propionate production was associated to the obese microbiome. In spite of the large interindividual variability, the obese phenotype seems to be defined more by the abundance and/or the absence of distinct communities of microorganism rather than by the presence of a specific population.
- 16 June 2021
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 11
Open AccessTaxonomic Characterization and Short-Chain Fatty Acids Production of the Obese Microbiota
Intestinal microbiota seems to play a key role in obesity. The impact of the composition and/or functionality of the obesity-associated microbiota have yet to be fully characterized. This work assessed the significance of the taxonomic composition and/or metabolic activity of obese- microbiota by massive 16S rRNA gene sequencing of the fecal microbiome of obese and normoweight individuals. The obese metabolic activity was also assessed by in vitro incubation of obese and normoweight microbiotas in nutritive mediums with different energy content. We found that the microbiome richness and diversity of the two groups did not differ significantly, except for Chao1 index, significantly higher in normoweight individuals. At phylum level, neither the abundance of Firmicutes or Bacteroidetes nor their ratio was associated with the body mass index. Besides, the relative proportions in Collinsella, Clostridium XIVa, and Catenibacterium were significantly enriched in obese participants, while Alistipes, Clostridium sensu stricto, Romboutsia, and Oscillibacter were significantly diminished. In regard to metabolic activity, short-chain fatty acids content was significant higher in obese individuals, with acetate being the most abundant followed by propionate and butyrate. Acetate and butyrate production was also higher when incubating obese microbiota in mediums mimicking diets with different energy content; interestingly, a reduced capability of propionate production was associated to the obese microbiome. In spite of the large interindividual variability, the obese phenotype seems to be defined more by the abundance and/or the absence of distinct communities of microorganism rather than by the presence of a specific population.
- 1 September 2019
- Published by Elsevier in International Dairy Journal
- Vol. 96, 29-35
Expression of amino acid converting enzymes and production of volatile compounds by Lactococcus lactis IFPL953
- 1 September 2019
- Published by Elsevier in International Dairy Journal
- Vol. 96, 29-35
Expression of amino acid converting enzymes and production of volatile compounds by Lactococcus lactis IFPL953
- Open Access
- 19 August 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Lyso-Gb3 modulates the gut microbiota and decreases butyrate production
Fabry disease is a rare X-linked lysosomal storage disorder resulting from deficient activity of α-galactosidase A, leading to the accumulation of glycosphingolipids such as globotriaosylsphingosine (lyso-Gb3). The gastrointestinal symptoms of this disease may be disabling, and the life expectancy of affected patients is shortened by kidney and heart disease. Our hypothesis was that lyso-Gb3 may modify the gut microbiota. The impact of a clinically relevant concentration of lyso-Gb3 on mono- or multispecies bacterial biofilms were evaluated. A complex bacterial community from the simulated transverse colon microbiota was studied using quantitative PCR to estimate different bacterial group concentrations and a HPLC was used to estimate short-chain fatty acids concentrations. We found that lyso-Gb3 increased the biofilm-forming capacity of several individual bacteria, including Bacteroides fragilis and significantly increased the growth of B. fragilis in a multispecies biofilm. Lyso-Gb3 also modified the bacterial composition of the human colon microbiota suspension, increasing bacterial counts of B. fragilis, among others. Finally, lyso-Gb3 modified the formation of short-chain fatty acids, leading to a striking decrease in butyrate concentration. Lyso-Gb3 modifies the biology of gut bacteria, favoring the production of biofilms and altering the composition and short-chain fatty-acid profile of the gut microbiota.
- 19 August 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Open AccessLyso-Gb3 modulates the gut microbiota and decreases butyrate production
Fabry disease is a rare X-linked lysosomal storage disorder resulting from deficient activity of α-galactosidase A, leading to the accumulation of glycosphingolipids such as globotriaosylsphingosine (lyso-Gb3). The gastrointestinal symptoms of this disease may be disabling, and the life expectancy of affected patients is shortened by kidney and heart disease. Our hypothesis was that lyso-Gb3 may modify the gut microbiota. The impact of a clinically relevant concentration of lyso-Gb3 on mono- or multispecies bacterial biofilms were evaluated. A complex bacterial community from the simulated transverse colon microbiota was studied using quantitative PCR to estimate different bacterial group concentrations and a HPLC was used to estimate short-chain fatty acids concentrations. We found that lyso-Gb3 increased the biofilm-forming capacity of several individual bacteria, including Bacteroides fragilis and significantly increased the growth of B. fragilis in a multispecies biofilm. Lyso-Gb3 also modified the bacterial composition of the human colon microbiota suspension, increasing bacterial counts of B. fragilis, among others. Finally, lyso-Gb3 modified the formation of short-chain fatty acids, leading to a striking decrease in butyrate concentration. Lyso-Gb3 modifies the biology of gut bacteria, favoring the production of biofilms and altering the composition and short-chain fatty-acid profile of the gut microbiota.